PCM
Price Capital Management Portfolio holdings
AUM $1.42M
1-Year Return
21.24%
This Quarter Return
+14.43%
1 Year Return
+21.24%
3 Year Return
+53.81%
5 Year Return
–
10 Year Return
–
AUM
$161M
AUM Growth
+$48M
(+42%)
Cap. Flow
+$39.1M
Cap. Flow
% of AUM
24.21%
Top 10 Holdings %
Top 10 Hldgs %
23.99%
Holding
322
New
258
Increased
–
Reduced
45
Closed
19
Top Buys
| 1 |
iShares Micro-Cap ETF
IWC
|
+$6.96M |
| 2 |
Health Care Select Sector SPDR Fund
XLV
|
+$6.03M |
| 3 |
iShares US Aerospace & Defense ETF
ITA
|
+$4.95M |
| 4 |
SPDR S&P Regional Banking ETF
KRE
|
+$4.21M |
| 5 |
SPDR S&P Biotech ETF
XBI
|
+$3.36M |
Top Sells
| 1 |
Consumers Staples Select Sector SPDR Fund
XLP
|
+$12.3M |
| 2 |
Vanguard Total International Bond ETF
BNDX
|
+$7.44M |
| 3 |
ABMD
Abiomed Inc
ABMD
|
+$2.23M |
| 4 |
IMPV
Imperva, Inc.
IMPV
|
+$2.18M |
| 5 |
RFMD
RF MICRO DEVICES INC
RFMD
|
+$2.17M |
Sector Composition
| 1 | Healthcare | 22.56% |
| 2 | Consumer Discretionary | 15.32% |
| 3 | Technology | 10.47% |
| 4 | Financials | 8.71% |
| 5 | Industrials | 7.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Bank of Hawaii
BOH
$2.65B
| $343K | 0.21% |
+5,609
| New | +$343K |
|
|
CYN
127
DELISTED
CITY NATIONAL CORPORATION
CYN
| $343K | 0.21% |
+3,853
| New | +$343K |
|
128
Bankunited
BKU
$2.88B
| $342K | 0.21% |
+10,461
| New | +$342K |
|
129
First Horizon
FHN
$11.4B
| $342K | 0.21% |
+23,921
| New | +$342K |
|
130
Repligen
RGEN
$6.8B
| $289K | 0.18% |
+9,526
| New | +$289K |
|
|
CBM
131
DELISTED
Cambrex Corporation
CBM
| $285K | 0.18% |
+7,197
| New | +$285K |
|
|
CBPO
132
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $277K | 0.17% |
+2,900
| New | +$277K |
|
133
BioMarin Pharmaceuticals
BMRN
$10.5B
| $267K | 0.17% |
+2,145
| New | +$267K |
|
|
LUMO
134
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $267K | 0.17% |
542
-3,001
| -85% | -$1.48M |
|
135
Regeneron Pharmaceuticals
REGN
$61.8B
| $259K | 0.16% |
+574
| New | +$259K |
|
|
MACK
136
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $256K | 0.16% |
2,738
-12,266
| -82% | -$1.15M |
|
137
Amgen
AMGN
$148B
| $253K | 0.16% |
+1,580
| New | +$253K |
|
|
NTUS
138
DELISTED
Natus Medical Inc
NTUS
| $253K | 0.16% |
6,400
-26,207
| -80% | -$1.04M |
|
139
Insmed
INSM
$30.6B
| $252K | 0.16% |
+12,102
| New | +$252K |
|
140
Deluxe
DLX
$903M
| $249K | 0.15% |
+3,600
| New | +$249K |
|
141
Incyte
INCY
$16.6B
| $249K | 0.15% |
+2,717
| New | +$249K |
|
142
American Airlines Group
AAL
$8.32B
| $248K | 0.15% |
+4,700
| New | +$248K |
|
143
Biogen
BIIB
$21.3B
| $247K | 0.15% |
+586
| New | +$247K |
|
144
Jazz Pharmaceuticals
JAZZ
$7.75B
| $247K | 0.15% |
+1,428
| New | +$247K |
|
145
Charles River Laboratories
CRL
$7.5B
| $246K | 0.15% |
+3,097
| New | +$246K |
|
|
ANDV
146
DELISTED
Andeavor
ANDV
| $246K | 0.15% |
+2,700
| New | +$246K |
|
|
ARIA
147
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $245K | 0.15% |
+29,749
| New | +$245K |
|
148
Axon Enterprise
AXON
$59.7B
| $244K | 0.15% |
10,100
-78,710
| -89% | -$1.9M |
|
149
Masimo
MASI
$7.7B
| $244K | 0.15% |
+7,400
| New | +$244K |
|
|
INFN
150
DELISTED
Infinera Corporation Common Stock
INFN
| $244K | 0.15% |
12,400
-70,748
| -85% | -$1.39M |
|